Epidemiology of Young Lung Cancer - Survey
This is a 100% virtual (remote), case-case study to explore potential environmental, lifestyle and genetic factors that may be associated with driver mutations of young lung cancer in the U.S.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Aug 4, 2026 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Observational
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Addario Lung Cancer Medical Institute
- Interventions being studied
- Other: Online Survey
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
1. Male or female aged 18 years and over; or the age of majority for their residential state at the time of enrollment 2. Documentation of primary NSCLC, any stage 3. Less than 50 years of age at the time of NSCLC diagnosis 4. Documentation of testing by a CLIA certified lab for genomic drivers of lung cancer 5. Willingness to undergo all study procedure 6. Provision of written informed consent
1. Male or female aged less than 18 years; or less than the age of majority for their residential state 2. Greater than or equal to 50 years of age at the time of NSCLC diagnosis 3. No documentation of mutation testing 4. Unwilling to undergo all study procedures 5. Unable or unwilling to provide consent
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- USC Keck School of MedicineLos Angeles, California
- Addario Lung Cancer Medical InstituteSan Carlos, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 4, 2026. Always confirm current availability with the study team.